Spyre Therapeutics, Inc 10-K for FY2021
Spyre Therapeutics, Inc. (SYRE)
10-K
2022-03-08
For: 2021-12-31
View Original
Added on
April 10, 2026
About this 10-K
Spyre Therapeutics, Inc filed this 10-K on March 8, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $18.74M
- compared with $0 a year earlier
- Net loss
- $65.8M
- compared with a net loss of $80.89M a year earlier